First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis. - Toscano S; Spelman T; Ozakbas S; Alroughani R; Chisari CG; Lo Fermo S; Prat A; Girard M; Duquette P; Izquierdo G; Eichau S; Grammond P; et al. (Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2025)